WEKO3
アイテム
Development of antipsychotics in Japan
https://aino.repo.nii.ac.jp/records/788
https://aino.repo.nii.ac.jp/records/78839e55c79-0715-4fde-9aba-6af98dc19bba
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
Development of antipsychotics in Japan (1.4 MB)
|
|
| Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 公開日 | 2022-07-13 | |||||||||||||
| タイトル | ||||||||||||||
| タイトル | Development of antipsychotics in Japan | |||||||||||||
| 言語 | en | |||||||||||||
| 言語 | ||||||||||||||
| 言語 | eng | |||||||||||||
| キーワード | ||||||||||||||
| 主題 | antipsychotics, first generation antipsychotics (FGA), second generation antipsychotics (SGA), serotomin-dopamine antagonist (SDA), Japanese Pharma | |||||||||||||
| 資源タイプ | ||||||||||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||||||||
| 資源タイプ | departmental bulletin paper | |||||||||||||
| 著者 |
Takeda, Masatoshi
× Takeda, Masatoshi
× Mizoguchi, Yukie
|
|||||||||||||
| 抄録 | ||||||||||||||
| 内容記述タイプ | Abstract | |||||||||||||
| 内容記述 | The era of pharmacotherapy in Japan was opened with chlorpromazine developed in 1955. Since then Japanese Pharmas were quite energetic in developing new antipsychotics with little modification. Availability of so many antipsychotics may have led Japanese psychiatric service too much relied on antipsychotics. The era of the second generation antipsychotics (SGA) in Japan began with introduction of risperidone in 1996. Since then Japanese Pharmas produced SGAs such as perospirone, blonanserin, and aripiprzol, some of which have attained a great success in the world. More and more SGAs will be introduced to Japanese market including brexpirazol, and lurasidone. Japanese psychiatrists are expected to be experts in utilizing these new SGAs, but it should be kept in mind of all psychiatrists that psychiatric service can be attained through the good practice in cooperation with the patients and their families and the role of antipsychotics should be re-evaluated considering the right direction in developing better clinical service to psychiatric patients. |
|||||||||||||
| 言語 | en | |||||||||||||
| 書誌情報 |
en : AINO JOURNAL 巻 16, 号 1, p. 73-87, ページ数 15, 発行日 2018-03-31 |
|||||||||||||
| 出版者 | ||||||||||||||
| 出版者 | AINO UNIVERSITY | |||||||||||||
| 言語 | en | |||||||||||||
| ISSN | ||||||||||||||
| 収録物識別子タイプ | PISSN | |||||||||||||
| 収録物識別子 | 1348-480X | |||||||||||||
